NIH-funded research R03 grant

Understanding how heparan sulfate affects bone formation through sclerostin interactions

Official title: Demystify Heparan Sulfate–Sclerostin Interactions in Bone Formation

Funded at Ohio State University · NIH-11199400 · Data updated 2026-11-12

This study is looking at how a substance called heparan sulfate interacts with a protein named sclerostin, which stops bones from growing, to help find new ways to treat osteoporosis and improve bone health.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startOctober 1, 2024
Project endJanuary 31, 2026
Funding year2024
Award (this year)$64,066
NIH project number7R03DE031838-03
Project IDNIH-11199400 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk of osteoporosis or those with conditions affecting bone density.

Less likely to help

Patients with conditions unrelated to bone formation or those who are not at risk for osteoporosis may not benefit from this research.

What this research studies

This research investigates the interactions between heparan sulfate and sclerostin, a protein that inhibits bone formation. By exploring how these interactions occur, the study aims to uncover the mechanisms that regulate sclerostin's activity in bone cells. The researchers will conduct experiments in the lab to determine how heparan sulfate influences the binding of sclerostin to its receptor, which could provide insights into new treatments for conditions like osteoporosis. The ultimate goal is to clarify the role of heparan sulfate in bone biology and its potential as a therapeutic target.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for enhancing bone formation and treating osteoporosis.

How similar studies have gone: While the specific interactions of heparan sulfate and sclerostin have not been extensively studied, related research has shown promise in targeting sclerostin for osteoporosis treatment.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Li, Miaomiao — Ohio State University
  • Study coordinator: Li, Miaomiao

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.